Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver

NCT00766220 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Slow Accrual and withdrawn/exclusion of 2 participants.

Conditions

Colon Cancer
Colorectal Cancer

Interventions

DRUG: SIR-spheres Agent Administration
DRUG: Cetuximab
DRUG: Irinotecan

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]